volume 68 issue 9 pages 1156-1158

Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog

W. J. A. VANDENHEUVEL 1
B.H. Arison 1
T.W. Miller 1
P Kulsa 1
P. Eskola 1
H Mrozik 1
A. K. Miller 2
H Skeggs 3
S B Zimmerman 2
B M Miller 2
1
 
Merck, Sharp and Dohme Research Laboratories, Rahway, NJ 07065.
2
 
Merck Institute for Therapeutic Research, Rahway, NJ 07065
3
 
Merck Sharp & Dohme Research Laboratories, West Point, PA 19486
Publication typeJournal Article
Publication date1979-09-01
scimago Q1
wos Q2
SJR0.737
CiteScore7.2
Impact factor3.8
ISSN00223549, 15206017
PubMed ID:  115987
Pharmaceutical Science
Abstract
The antiprotozoal drug 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole (I), which exhibits activity against trypanosomiasis, is also antibacterial in vivo. Since the urine from a dog dosed with I showed a broader spectrum of antibacterial activity than I itself, metabolites from this urine were isolated and partially characterized. The metabolites were mono- and dihydroxy-substituted species with the hydroxyl groups on carbons 4--7 of the hexahydrobenzisoxazole ring. These observations led to the synthesis of several such hydroxy derivatives of I, and their properties fully supported the proposed positions of metabolic hydroxylation. One synthetic compound, the 6,7-cis-dihydroxy compound, exhibited higher antibacterial activity against Salmonella schottmuelleri in mice and greater trypanocidal activity in vivo against Trypanosoma cruzi (Brazil strain) than I.
Found 
Found 

Top-30

Journals

1
2
3
Journal of Pharmaceutical Sciences
3 publications, 33.33%
Mutation Research/Genetic Toxicology
1 publication, 11.11%
Xenobiotica
1 publication, 11.11%
Synthetic Communications
1 publication, 11.11%
Annual Reports in Medicinal Chemistry
1 publication, 11.11%
1
2
3

Publishers

1
2
3
4
5
Elsevier
5 publications, 55.56%
Taylor & Francis
2 publications, 22.22%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
9
Share
Cite this
GOST |
Cite this
GOST Copy
VANDENHEUVEL W. J. A. et al. Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog // Journal of Pharmaceutical Sciences. 1979. Vol. 68. No. 9. pp. 1156-1158.
GOST all authors (up to 50) Copy
VANDENHEUVEL W. J. A., Arison B., Miller T., Kulsa P., Eskola P., Mrozik H., Miller A. K., Skeggs H., Zimmerman S. B., Miller B. M. Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog // Journal of Pharmaceutical Sciences. 1979. Vol. 68. No. 9. pp. 1156-1158.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/jps.2600680926
UR - https://doi.org/10.1002/jps.2600680926
TI - Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog
T2 - Journal of Pharmaceutical Sciences
AU - VANDENHEUVEL, W. J. A.
AU - Arison, B.H.
AU - Miller, T.W.
AU - Kulsa, P
AU - Eskola, P.
AU - Mrozik, H
AU - Miller, A. K.
AU - Skeggs, H
AU - Zimmerman, S B
AU - Miller, B M
PY - 1979
DA - 1979/09/01
PB - Elsevier
SP - 1156-1158
IS - 9
VL - 68
PMID - 115987
SN - 0022-3549
SN - 1520-6017
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1979_VANDENHEUVEL,
author = {W. J. A. VANDENHEUVEL and B.H. Arison and T.W. Miller and P Kulsa and P. Eskola and H Mrozik and A. K. Miller and H Skeggs and S B Zimmerman and B M Miller},
title = {Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog},
journal = {Journal of Pharmaceutical Sciences},
year = {1979},
volume = {68},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1002/jps.2600680926},
number = {9},
pages = {1156--1158},
doi = {10.1002/jps.2600680926}
}
MLA
Cite this
MLA Copy
VANDENHEUVEL, W. J. A., et al. “Urinary Metabolites of 3a,4,5,6,7,7a‐Hexahydro‐3‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,2‐benzisoxazole in the Dog.” Journal of Pharmaceutical Sciences, vol. 68, no. 9, Sep. 1979, pp. 1156-1158. https://doi.org/10.1002/jps.2600680926.